Back
Exelixis Vs. ADMA Biologics Industry Stock Comparison
Buy
84
EXEL
Exelixis
Last Price:
35.62
Seasonality Move:
13.23%
Buy
72
ADMA
ADMA Biologics
Last Price:
21.19
Seasonality Move:
2.51%
Buy
84
Exelixis (EXEL)
is a Buy
Is Exelixis a Buy, Sell or Hold?
- The current Exelixis [EXEL] share price is $35.61. The Score for EXEL is 84, which is 68% above its historic median score of 50, and infers lower risk than normal.
- EXEL is currently trading in the 80-90% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.
Buy
72
ADMA Biologics (ADMA)
is a Buy
Is ADMA Biologics a Buy, Sell or Hold?
- The current ADMA Biologics [ADMA] share price is $21.18. The Score for ADMA is 72, which is 44% above its historic median score of 50, and infers lower risk than normal.
- ADMA is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
ADMA Stock Price Chart
What is ADMA Biologics's stock price today?
-
The ADMA Biologics share price today is $21.18
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ADMA is experiencing slight buying pressure.
EXEL Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.59 | Buy |
| Relative Strength Index (14 RSI): | 72.44 | Buy |
| Chaikin Money Flow: | 1478964 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (30.05 - 36.05) | Buy |
| Bollinger Bands (100): | (23.18 - 31.22) | Buy |
ADMA Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.85 | Buy |
| Relative Strength Index (14 RSI): | 59.66 | Buy |
| Chaikin Money Flow: | 0 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (16.6 - 21.28) | Buy |
| Bollinger Bands (100): | (13.82 - 19.88) | Buy |
EXEL Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 34.84 | Buy |
| 20-day SMA: | 34.22 | Buy |
| 50-day SMA: | 29.85 | Buy |
| 200-day SMA: | 24.68 | Buy |
| 8-day EMA: | 34.93 | Buy |
| 20-day EMA: | 33.75 | Buy |
| 50-day EMA: | 30.88 | Buy |
| 200-day EMA: | 25.85 | Buy |
ADMA Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 20.59 | Buy |
| 20-day SMA: | 19.74 | Buy |
| 50-day SMA: | 18.9 | Buy |
| 200-day SMA: | 12.2 | Buy |
| 8-day EMA: | 20.77 | Buy |
| 20-day EMA: | 19.94 | Buy |
| 50-day EMA: | 18.68 | Buy |
| 200-day EMA: | 13.49 | Buy |
Exelixis Earnings Growth & EXEL Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.14 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.09 per share, and an increase next year of $0.01 per share.
ADMA Biologics Earnings Growth & ADMA Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.54 per share, and an increase next year of $0.22 per share.
Exelixis Technical Analysis
| Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
ADMA Biologics Technical Analysis
| Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||